A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation

Type of Cancer
Neuro-Oncology

Sponsor
Alliance

Protocol Number
A071102

To Learn More Call
(201)-510-0950